Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.93 USD | +0.60% | +2.75% | +19.98% |
04-29 | Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER | CI |
04-11 | Collegium Pharmaceutical to Redeem $26.35 Million of Senior Notes | MT |
Evolution of the average Target Price on Collegium Pharmaceutical, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Collegium Pharmaceutical, Inc.
Piper Sandler | |
Truist Securities | |
Jefferies & Co. | |
Needham & Co. | |
HC Wainwright | |
Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- COLL Stock
- Consensus Collegium Pharmaceutical, Inc.